Status and phase
Conditions
Treatments
About
The use of chondroitin sulfate and glucosamine sulfate has been recognized since the 70 decade in the treatment of osteoarthritis. Numerous clinical trials have demonstrated the therapeutic properties of this association in control of osteoarthritis, especially in reducing pain and improving movement. The combination of chondroitin sulfate with glucosamine sulfate offers a significantly higher tolerance than most drug treatments and, moreover, has long lasting effects even after stopping treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Constitute the criteria for inclusion in the study:
Constitute the criteria for exclusion from the study:
Use of corticosteroids orally or intramuscularly, fast action, for up to two weeks before V-1 or 14 days before the scheduled visits Use of oral corticosteroids or intramuscular depot for up to 4 weeks before V-1 or 14 days before the scheduled visits the administration of intra-articular corticosteroids in the study joint in the 3 months prior to randomization visit (V0) or during the study the administration of intra-articular corticosteroid into any other joint for up to 4 weeks prior to randomization visit (V0) or during the study
Primary purpose
Allocation
Interventional model
Masking
320 participants in 4 patient groups
Loading...
Central trial contact
Rosa Marcolino Sergio, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal